Liraglutide Injection, Solution
Product Images NDC 70377-095

Product Visual Gallery

This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Liraglutide (NDC 70377-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton5s.jpg (Carton5s)

This text provides information about a medication called Liraglutide Injection, which comes in a prefilled pen containing 18 mg/3 mL doses. It is intended for subcutaneous use and should be refrigerated but not frozen. The pen should be discarded after 30 days of first use and should be used with specific disposable needles. The text also includes instructions on storage, contacting a pharmacist if the seal is broken, the ingredients of the medication, and the trademarks of the brands mentioned.*

FDA Label Image

Structural Formula (Image 01)

This appears to be a list of amino acids: Histidine (His), Alanine (Ala), Glutamine (Glu), Glycine (Gly), Threonine (Thr), Phenylalanine (Phe), and Threonine (Thr). Amino acids are essential building blocks of proteins and play crucial roles in various biological processes.*

FDA Label Image

Fig. 5 (Image 02)

FDA Label Image

Figure A (Image 08)

FDA Label Image

Image 02 (Image 09)

FDA Label Image

Image 3 (Image 10)

This text represents the results of a study comparing the effect of Liraglutide versus Placebo on body weight change over a certain period of time. The study includes data on the change in body weight percentages observed in patients on the study drug completing scheduled visits. The information also includes multiple imputations for intention-to-treat (ITT) analysis. The results are presented in two separate studies.*

FDA Label Image

Figure B (Image 11)

FDA Label Image

Image 4 (Image 12)

FDA Label Image

Device (Image 47)

This text appears to describe various parts and features of a pen used for injecting medication. It includes items such as a pen cap, pen scale, pen window, dose counter, dose pointer, dose selector, dose button, outer and inner needle caps, needle, paper tab, and a flow check symbol. It seems to provide information on how to operate and use the pen for administering doses of medication.*

FDA Label Image

Figure C (Image 48)

FDA Label Image

Figure D (Image 49)

FDA Label Image

Figure E (Image 50)

FDA Label Image

Note (Image 51)

FDA Label Image

Information (Image 52)

FDA Label Image

Figure F (Image 53)

FDA Label Image

Flow Check Symbol (Image 54)

FDA Label Image

Figure G (Image 55)

This text is not readable.*

FDA Label Image

Note (Image 56)

FDA Label Image

Information (Image 57)

FDA Label Image

Figure H (Image 58)

FDA Label Image

Note (Image 59)

FDA Label Image

Information (Image 60)

FDA Label Image

Figure I (Image 61)

FDA Label Image

Information (Image 62)

FDA Label Image

Figure J (Image 63)

FDA Label Image

Information (Image 64)

FDA Label Image

Note (Image 65)

FDA Label Image

Figure K (Image 66)

This text provides information about a remaining dose of 2.4 mg. It seems to be related to tracking medication usage.*

FDA Label Image

Figure L (Image 67)

FDA Label Image

Figure M (Image 68)

FDA Label Image

Figure N (Image 69)

FDA Label Image

Note (Image 70)

FDA Label Image

Information (Image 71)

FDA Label Image

Figure O (Image 72)

FDA Label Image

Figure P (Image 73)

FDA Label Image

Figure Q (Image 74)

FDA Label Image

Figure R (Image 75)

FDA Label Image

Information (Image 76)

FDA Label Image

Note (Image 77)

FDA Label Image

Information (Image 78)

FDA Label Image

Figure S (Image 79)

FDA Label Image

Note (Image 80)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.